The clinical testing of the first digital therapy solution

“Vigo Health” in cooperation with Riga Stradiņš University (RSU) starts the clinical testing of a digital therapy solution for stroke survivors, the first of its kind in Latvia. Stroke is the leading cause of death and disability worldwide, resulting in consuming a significant 34% of the overall healthcare costs.

Vigo Health provides remote rehabilitation software “Vigo” that helps patients overcome functional, cognitive, and emotional consequences at the comfort of their own home. Already now it has helped more than 100 stroke survivors. Like all medical interventions, “Vigo” needs to be built on a solid evidence base of its medical and economic effectiveness. That is the reason the clinical testing process has been launched – the clinical testing is divided into several stages and the first phase of the study is currently initiated.

“This is a historic moment. For the first time in Latvia a clinical study is being conducted on a digital therapy solution, moreover, it is also one that originates from Latvia. RSU and Vigo Health have already collaborated on research before, as RSU has excellent specialists and infrastructure for such research,” comments Dr. Jānis Šlēziņš, neurosurgeon and a co-founder of Vigo Health.

Source: labsoflatvia.com